首页> 美国卫生研究院文献>BMJ Case Reports >Case Report: Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression
【2h】

Case Report: Neostigmine and glycopyrronium: a potential safe alternative for patients with pseudo-obstruction without access to conventional methods of decompression

机译:病例报告:新斯的明和格隆铵:对于假性梗阻患者而无需使用常规减压方法的一种潜在的安全替代方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Intestinal pseudo-obstruction mimics bowel obstruction. However, on examination, no mechanical cause is identified. This condition will often resolve when managed conservatively, yet in some cases decompression is required to avoid the serious complications of bowel ischaemia and perforation. This is performed endoscopically, and due to the invasive nature and limited access to this service, an alternative treatment option is deemed appealing. Neostigmine has good efficacy in the decompression of pseudo-obstruction but is hindered by its wide side effect profile. In this context, neostigmine requires careful monitoring, which limits its appeal. This side effect profile is minimised when neostigmine is administered in conjunction with glycopyrronium.This case demonstrates the novel use of neostigmine and glycopyrronium in decompression of the bowel in a patient with pseudo-obstruction. Furthermore, it highlights its value, particularly when conventional techniques for decompression are not accessible.
机译:肠假性梗阻模仿肠梗阻。但是,经检查,没有发现机械原因。当保守治疗时,这种情况通常会解决,但是在某些情况下,需要减压以避免肠缺血和穿孔的严重并发症。这是在内窥镜下进行的,并且由于其侵入性和获得此项服务的机会有限,一种替代治疗选择被认为具有吸引力。新斯的明在缓解假性阻塞方面具有良好的疗效,但其副作用范围广。在这种情况下,新斯的明需要进行仔细的监测,这限制了它的吸引力。当新斯的明与格隆溴铵联用时,这种副作用会降到最低。该病例证明了新斯的明和格隆溴铵在假性肠梗阻患者肠道减压中的新用途。此外,它突出了其价值,特别是在无法使用常规减压技术的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号